A "Phantom Recall" Does Not Comport with FDA's Regulatory Practice--Or Does It?: The Need for More Stringent Mandatory Reporting in FDA Matters.Published in:Iowa Law Review, 2012, v. 97, n. 5, p. 1839By:Tennyson, Eleanor G.Publication type:Article
J&J fined US$1.1bn for illegal marketing.Published in:TCE: The Chemical Engineer, 2012, n. 851, p. 15Publication type:Article
Seven days: 13-19 April 2012.Published in:Nature, 2012, v. 484, n. 7394, p. 292, doi. 10.1038/484292aPublication type:Article
J&J courts biotech in clusters.Published in:Nature Biotechnology, 2013, v. 31, n. 9, p. 769, doi. 10.1038/nbt0913-769By:Senior, MelaniePublication type:Article
Third-quarter biotech job picture.Published in:Nature Biotechnology, 2012, v. 30, n. 11, p. 1149, doi. 10.1038/nbt.2417By:Francisco, MichaelPublication type:Article